Spinal cord metastatic glioblastoma multiforme of childhood: Case report;Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: Relato de caso

Arquivos de Neuro-Psiquiatria

Volumn 60, Issue 3 A, 2002, Pages 643-646

  Rondinelli, Patricia Imperatriz Porto ^a,b   Martinez, Carlos Alberto Osório ^a  

^a Med Res Center Hospital do Cancer   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Glioblastoma multiforme; Spinal metastasis

Indexed keywords

ARTICLE; BRAIN TUMOR; CASE REPORT; CHILD; FATALITY; FEMALE; GLIOBLASTOMA; HUMAN; METASTASIS; PATHOLOGY; SPINAL CORD TUMOR;

BRAIN NEOPLASMS; CHILD; FATAL OUTCOME; FEMALE; GLIOBLASTOMA; HUMANS; SPINAL CORD NEOPLASMS; SUPRATENTORIAL NEOPLASMS;

EID: 0348237074     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2002000400025     Document Type: Article

References (30)

1. Campbell JN, Pollack IF, Martinez AJ, et al. High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 1996;38:258-264.
2. Winger MJ, MacDonald DR, Cairncross JG, et al. Supratentorial anaplastic gliomas in adults: the prognostic importance of extent of resection and prior low-grade glioma. J Neurosusrg 1988;68:684-688.
3. Rorke LB, Gilles FH, Davis RL, et al. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 1992;56:1869-1886.
4. Salcman M. Glioblastoma and malignant astrocytoma. In Kaye AH, Laws ER Jr. Brain tumors: an encyclopedic approach. New York: Churchill-Livisgtone,1995: 449-477.
5. Wiltshire RN. Comparative genetic patterns of glioblastoma multiforme: potencial diagnostic tool for tumor classification. Neuro-Oncol 2000;2:164-173.
6. Levin VA, Ashby LS, Shapiro WR, et al. Phase II study of 6-thioguanine, procarbazine, dibomodulcitol, lomustine and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Neuro-Oncol 2000;2:22-28.
7. Burger PC. Classification and biology of brain tumors. In Youmans JR (ed). Neurological surgery: a comprehensive reference guide to the diagnosis and management of neurosurgical problems. Philadelphia: Saunders, 1990: 2906-2999.
8. Huang F, Kanno H, Yamamoto I, et al. Correlation of clinical features and telomerase activity in human gliomas. J Neuro-Oncol 1999;43:137-142.
9. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic glioma: a cooperative clinical trial. J Neurosurg 1978;49:333-343.
10. Shapiro S, Mealey J, Sartorious C, et al. Radiation-induced intracranial malignant gliomas. J Neurosurg 1993;71:77-82.
11. Packer RJ, Vezina G. Pediatric glial neoplasms including brain-stem gliomas. Semin Oncol 1994;21:260-272.
12. Laws ER, Taylor WF, Clifton MB, et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984;61:665-673.
13. Wisoff JH, Boyet J, Brandt K, et al. Neurosurgical management and influence of extent of resection on survival in pediatric high-grade astrocytomas: a report of the CCG 945. J Neurosurg 1993;78:344.
14. Warr T, Ward S, Burrows J, et al. Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults. Genes, Chomosomes & Cancer 2001;31:15-22.
15. Tribius S. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiot Oncol Biol Phys 2001;50:511-523.
16. Mirabell R, Mornex F, Greiner R, et al. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer Trial 22933. J Clin Oncol 1999;17:3143-3149
17. Sneed PK, Russo C, Scharfen CO, et al. Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors. Pediatr Neurosurg 1996;24:314-322.
18. Fischer BJ, Scott C, Macdonald DR, et al. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of radiation therapy oncology group trial 9507. J Clin Oncol 2001;19:1111-1117.
19. Dropcho EJ, Wisoff JH, Walker RW, rt al. Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol 1987;22:355-364.
20. Daumas-Duport C, Schetihauer B, O'Fallon J, et al. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152-2165.
21. Salcman M. Glioblastoma and malignant astrocytoma. In Kaye AH, Laws ER Jr (eds). Brain tumors: an encyclopedic approach. New York: Churchill Livingstone, 1995:449-477.
22. Frenay M, Lebrun C, Lonjon M, et al. UP-front chemotherapy with fotemustine/cisplatin/etoposide regimen in the treatment of 33 non-removable glioblastomas. Eur J Cancer 2000;36:1026-1031.
23. Osoba D, Brada M, Yung WKA, et al. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol 2000;18:1481-1491.
24. van der Bent MJ, Pronk L, PSillevis PAE, et al. Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma. J Neuro-Oncol 1999;44:59-64.
25. Meyers CA, Hess KR, Yung WKA, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 2000;18:646-650.
26. Hess KR. Extent of ressection as a prognostic variabble in the treatment of gliomas. J Neuro-Oncol 1999;42:227-231.
27. Pollack IF. The role of surgery in pediatric gliomas. J Neuro-Oncol 1999;42:271-288.
28. Rafel C. Molecular biology of pediatric barin tumors. In Encyclopedia of Cancer VoI 1: The molecular basis of neurosurgical disease. New York: Academic Press, 1997: 100-105.
29. Prados MD, Scott C, Curran WJ, et al. Future directions in the treatment of malignant gliomas with temozolomide. Semin Oncol 2001;27(Suppl):41-46.
30. Kraus JA. Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol 2001;101:311-320.